10.69
price up icon2.69%   0.28
after-market Handel nachbörslich: 10.84 0.15 +1.40%
loading

Rocket Pharmaceuticals Inc Aktie (RCKT) Neueste Nachrichten

pulisher
Jan 28, 2025

Rocket Pharmaceuticals appoints new board member By Investing.com - Investing.com Nigeria

Jan 28, 2025
pulisher
Jan 28, 2025

Rocket Pharmaceuticals appoints new board member - Investing.com

Jan 28, 2025
pulisher
Jan 28, 2025

Rocket Pharmaceuticals, Inc. Announces Board Changes -January 28, 2025 at 06:03 am EST - Marketscreener.com

Jan 28, 2025
pulisher
Jan 28, 2025

Rocket Pharmaceuticals vice president sells $9,300 in stock - MSN

Jan 28, 2025
pulisher
Jan 28, 2025

(RCKT) Technical Pivots with Risk Controls - Stock Traders Daily

Jan 28, 2025
pulisher
Jan 27, 2025

Rocket Pharmaceuticals vice president sells $9,300 in stock By Investing.com - Investing.com Canada

Jan 27, 2025
pulisher
Jan 25, 2025

Leerink Partnrs Has Strong Forecast for RCKT FY2024 Earnings - Defense World

Jan 25, 2025
pulisher
Jan 24, 2025

FY2024 Earnings Estimate for RCKT Issued By Leerink Partnrs - MarketBeat

Jan 24, 2025
pulisher
Jan 24, 2025

Analysts Offer Predictions for RCKT FY2025 Earnings - Defense World

Jan 24, 2025
pulisher
Jan 23, 2025

Cantor Fitzgerald Predicts RCKT FY2025 Earnings - MarketBeat

Jan 23, 2025
pulisher
Jan 23, 2025

Rocket Pharmaceuticals (NASDAQ:RCKT) Sets New 52-Week LowHere's What Happened - MarketBeat

Jan 23, 2025
pulisher
Jan 23, 2025

Analysts Set Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Price Target at $47.27 - MarketBeat

Jan 23, 2025
pulisher
Jan 23, 2025

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Given Average Rating of “Moderate Buy” by Analysts - Defense World

Jan 23, 2025
pulisher
Jan 21, 2025

RCKT stock touches 52-week low at $10.11 amid market challenges - MSN

Jan 21, 2025
pulisher
Jan 19, 2025

Rocket Pharmaceuticals (NASDAQ:RCKT) Sets New 12-Month Low – Time to Sell? - Defense World

Jan 19, 2025
pulisher
Jan 17, 2025

Rocket Pharmaceuticals (NASDAQ:RCKT) Stock Price Down 4%Here's Why - MarketBeat

Jan 17, 2025
pulisher
Jan 17, 2025

How to Take Advantage of moves in (RCKT) - Stock Traders Daily

Jan 17, 2025
pulisher
Jan 16, 2025

Rocket Pharmaceuticals (RCKT) Loses -12.5% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - MSN

Jan 16, 2025
pulisher
Jan 16, 2025

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Shares Acquired by Mirador Capital Partners LP - MarketBeat

Jan 16, 2025
pulisher
Jan 13, 2025

JPMorgan Chase & Co. Decreases Position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World

Jan 13, 2025
pulisher
Jan 10, 2025

Rocket Pharmaceuticals (NASDAQ:RCKT) Hits New 12-Month LowHere's What Happened - MarketBeat

Jan 10, 2025
pulisher
Jan 07, 2025

Rocket Pharmaceuticals (NASDAQ:RCKT) Shares Up 6.9%Time to Buy? - MarketBeat

Jan 07, 2025
pulisher
Jan 06, 2025

Learn to Evaluate (RCKT) using the Charts - Stock Traders Daily

Jan 06, 2025
pulisher
Jan 06, 2025

RCKTRocket Pharmaceuticals, Inc. Latest Stock News & Market Updates - StockTitan

Jan 06, 2025
pulisher
Jan 02, 2025

Rocket Pharmaceuticals to Participate in the 43rd Annual J.P. Morgan Healthcare Conference - BioSpace

Jan 02, 2025
pulisher
Jan 02, 2025

Q4 Earnings Estimate for RCKT Issued By Wedbush - Defense World

Jan 02, 2025
pulisher
Jan 01, 2025

Brokers Set Expectations for RCKT Q4 Earnings - MarketBeat

Jan 01, 2025
pulisher
Dec 31, 2024

Rocket Pharmaceuticals (NASDAQ:RCKT) Trading 3.7% HigherWhat's Next? - MarketBeat

Dec 31, 2024
pulisher
Dec 31, 2024

Wedbush starts Rocket Pharmaceuticals with Outperform into ‘inflection year’ - Yahoo Finance

Dec 31, 2024
pulisher
Dec 31, 2024

Rocket Pharmaceuticals (NASDAQ:RCKT) Now Covered by Analysts at Wedbush - Defense World

Dec 31, 2024
pulisher
Dec 30, 2024

Rocket Pharmaceuticals' SWOT analysis: gene therapy stock poised for growth - Investing.com Canada

Dec 30, 2024
pulisher
Dec 30, 2024

Rocket Pharmaceuticals (NASDAQ:RCKT) Now Covered by Wedbush - MarketBeat

Dec 30, 2024
pulisher
Dec 29, 2024

Rocket Pharmaceuticals, Inc. (RCKT): Is This Gene Therapy Stock a Good Buy Right Now? - Yahoo Finance

Dec 29, 2024
pulisher
Dec 29, 2024

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat

Dec 29, 2024
pulisher
Dec 28, 2024

10 Best Gene Therapy Stocks to Buy Right Now - Insider Monkey

Dec 28, 2024
pulisher
Dec 27, 2024

(RCKT) On The My Stocks Page - Stock Traders Daily

Dec 27, 2024
pulisher
Dec 27, 2024

Geode Capital Management LLC Boosts Stock Position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World

Dec 27, 2024
pulisher
Dec 23, 2024

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Position Decreased by HighTower Advisors LLC - Defense World

Dec 23, 2024
pulisher
Dec 19, 2024

Rocket Pharmaceuticals Stock Soars as Jefferies Initiates Coverage at 'Buy' - MSN

Dec 19, 2024
pulisher
Dec 19, 2024

Rocket Pharmaceuticals (NASDAQ:RCKT) Sets New 1-Year LowHere's Why - MarketBeat

Dec 19, 2024
pulisher
Dec 19, 2024

State Street Corp Buys 322,156 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World

Dec 19, 2024
pulisher
Dec 19, 2024

Franklin Resources Inc. Cuts Stock Holdings in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - MarketBeat

Dec 19, 2024
pulisher
Dec 19, 2024

State Street Corp Has $57.29 Million Stake in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - MarketBeat

Dec 19, 2024
pulisher
Dec 18, 2024

Rocket Pharmaceuticals' SWOT analysis: gene therapy stock faces pivotal year - Investing.com

Dec 18, 2024
pulisher
Dec 18, 2024

Rocket Pharmaceuticals (NASDAQ:RCKT) Shares Gap UpShould You Buy? - MarketBeat

Dec 18, 2024
pulisher
Dec 18, 2024

Rocket Pharmaceuticals (NASDAQ:RCKT) Now Covered by Jefferies Financial Group - MarketBeat

Dec 18, 2024
$352.30
price down icon 5.49%
$41.04
price up icon 0.79%
$22.36
price up icon 3.33%
$5.41
price up icon 3.84%
biotechnology ONC
$226.89
price up icon 0.08%
$120.88
price down icon 0.23%
Kapitalisierung:     |  Volumen (24h):